4DMedical (ASX:4DX) received regulatory approval for its CT Lung Ventilation Analysis Software in Canada, according to a Tuesday filing with the Australian bourse.
The software, which already has regulatory approvals in the US and Australia, enables clinicians to assess lung ventilation using standard CT scans, per the filing.
It has been classified as a Class 2 medical device in Canada, the respiratory imaging technology company said in the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.